Kenshiro Takemoto

9PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 01, 2026
Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.

|Feb 26, 2026
KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma.

Yoshinori Nakano, Yohei Sekino, Go Kobayashi

|Jan 26, 2026
Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis.

Tomoya Hatayama, Yohei Sekino, Go Kobayashi

|Nov 29, 2025
Crucial Contribution of BACH1 to Bladder Cancer Progression via Upregulating Epithelial-Mesenchymal Transition Pathway.

Tomoya Hatayama, Kenshiro Takemoto, Kohei Kobatake

|Sep 15, 2025
Efficacy of Open-Ended Urinary Catheters in Preventing Catheter-Related Bladder Discomfort: A Randomized Controlled Trial.

Kohei Kobatake, Keisuke Goto, Tomoya Hatayama

|Sep 02, 2025
Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer Treatment.

Kazuma Yukihiro, Yohei Sekino, Go Kobayashi

Pageof 2

Frequent Collaborators

9 joint publications

Nobuyuki Hinata

7 joint publications

Kohei Kobatake

6 joint publications

Miki Naito

6 joint publications

Shunsuke Miyamoto